MedInCell
MEDCL.PADrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Ivermectin Tablets | Phase 2 | COVID-19 | - | - |
Frequently asked questions
What is in MedInCell's drug pipeline?→
CatalystAlert tracks 1 drug candidate in MedInCell's (MEDCL.PA) pipeline across Phase 2. Its lead program is Ivermectin Tablets (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MedInCell's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for MedInCell (MEDCL.PA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MEDCL.PA biotech catalysts?→
Add MEDCL.PA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MedInCell's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.